Last reviewed · How we verify

NCT06643572

Comparing of Using Patient Imaging and Virtual Reality-based Simulation Prior to Lumbar Transforaminal Injections

Completed NA Last updated 31 March 2026
What this trial tests

NA trial testing Virtual reality simulator in Lumbar Radiculopathy in 30 participants. Completed in 10 March 2026.

Timeline
1 January 2025
Primary endpoint
6 March 2026
10 March 2026

Quick facts

Lead sponsorKorea University Anam Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment30
Start date1 January 2025
Primary completion6 March 2026
Estimated completion10 March 2026
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Korea University Anam Hospital

Who can join

20 and older, any sex, with Lumbar Radiculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the impact of pre-procedure training using a 3D simulator, based on lumbar CT images, on the success rate and efficiency of lumbar transforaminal steroid injections in patients who are expected to be difficult to treat. The training is provided to practitioners prior to performing the procedure on these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual reality simulator

Trials testing the same drug.

Other recruiting trials for Lumbar Radiculopathy

Currently open trials in the same condition.

Other Korea University Anam Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06643572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing